Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
Most prognostic scales are designed to inform clinical judgment, but in no way supersede it. In the event of contradiction, the experienced clinician’s opinion should prevail . As George Box said, “Essentially all models are wrong, but some are useful.”
The uncertainty of each FN episode is inversely...
Priscilla Chase Duran for editing and improving this manuscript.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study, no informed consent is required.
- 3.Taplitz RA, Kennedy EB, Flowers CR. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update summary. J Oncol Pract. 2018;14(4):250–5.CrossRefPubMedGoogle Scholar
- 6.Carmona-Bayonas A, Jiménez-Fonseca P, Echaburu JV, Antonio M, Font C, Biosca M, et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J Clin Oncol. 2015;33(5):465–71.CrossRefPubMedGoogle Scholar
- 8.Hae M. Validation of clinical index of stable febrile neutropenia (CISNE) model: can it guide emergency physicians to a reasonable decision on outpatient vs. hospitalization? 2018 MASCC/ISOO annual meeting. Supp Care Cancer. 2018;26(Supplement 2):39–364.Google Scholar